Late Breaking Abstract - Plasma Metabolomic Signature Accurately Discriminates Frequent Exacerbators among COPD Patients - Amsterdam 2025

Omics-driven insights into acute and chronic lung disease: from molecular signatures to therapeutic targets

Chair(s): Aurélien Justet, Olivier Burgy

Session type: Poster session

Late Breaking Abstract - Plasma Metabolomic Signature Accurately Discriminates Frequent Exacerbators among COPD Patients

César Jessé Enríquez Rodríguez

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

The effect of mepolizumab on blood eosinophil subtype granule protein gene expression in severe eosinophilic asthma

Airidas Rimkunas

Poster

Abstract

Whole blood transcriptomic profile effects of benralizumab or mepolizumab in eosinophilic granulomatosis with polyangiitis

Daniel Muthas

Poster

Abstract

In silico exploration of the long and circular non-coding RNA network associated with Idiopathic Pulmonary Fibrosis

Periklis Marnas

Poster

Abstract

Associations between patient-reported outcome measures and omics data (PROMICs) in adults with asthma: results from the U-BIOPRED study

Guilherme Rodrigues

Poster

Abstract

Transcriptomic determinants of response to biological therapy in severe asthma: a prospective study

Fco.de Borja Garcia-cosio Piqueras

Poster

Abstract

Transcriptomic bronchial biopsy profiles specific to asthma remission

Hui Wen

Poster

Abstract

The nasal airway transcriptome reflects lower airway asthma-associated gene expression profiles

Hui Wen

Poster

Abstract

Label-free 3D imaging of asthmatic airway biopsies

Sylvia Spies

Poster

Abstract

Spatially resolved expression profiling of lung function impairment candidate causal genes in the airway epithelium of COPD and IPF patients.

Rohan Paranjpe

Poster

Abstract

Spectral flow cytometry analysis revealed peripheral blood immune cell population changes in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease

Elizabeth Guinto

Poster

Abstract

Using Spatial transcriptomics to profile selected candidate causal genes in lung epithelial regions of COPD and IPF patients

Holly Pedley

Poster

Abstract

Spatially resolved expression profiling of lung function impairment candidate causal genes in the airway smooth muscle of COPD and IPF patients.

Rohan Paranjpe

Poster

Abstract

Protein Expression-Based Models for Differentiating Idiopathic Pulmonary Fibrosis from Non-IPF Interstitial Lung Diseases

Abstract

Unveiling Gene Signatures of UIP-like Progression from Airway-Centric Interstitial Fibrosis

Andrea Jazel Rodríguez Herrera

Poster

Abstract

Reanalysis of WES data reveals new candidate genes for primary ciliary dyskinesia and beyond

Tilbe Hakçil Öz

Poster

Abstract

Gene expression analysis identifies potential therapeutic targets in idiopathic pulmonary fibrosis

Samin Abbasidezfouli

Poster

Abstract

Effects of benralizumab on serum biomarkers and biomarker response after shifting from mepolizumab to benralizumab in eosinophilic granulomatosis with polyangiitis (EGPA)

Daniel Muthas

Poster

Abstract

Late Breaking Abstract - Plasma Metabolomic Signature Accurately Discriminates Frequent Exacerbators among COPD Patients

César Jessé Enríquez Rodríguez

Poster

Abstract

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}